| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | TRERF1 TCF4 URI1 ATN1 MED14 ARID1A USP21 NCOR2 ARID1B KMT2D TCERG1 TLE1 TLE4 BRD4 HELZ2 IRF2BPL | 5.29e-06 | 562 | 150 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | chromatin binding | TCF4 URI1 TOX FOXN4 SAMD7 MBD6 ARID1A NCOR2 PHC3 ARID1B ATXN7 TLE1 TLE4 BRD4 KMT2A MNT BAHCC1 | 4.16e-05 | 739 | 150 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 6.00e-05 | 229 | 150 | 9 | GO:0003714 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 6.56e-05 | 11 | 150 | 3 | GO:0099122 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | TRERF1 ATN1 MED14 ARID1A USP21 ARID1B KMT2D TCERG1 BRD4 HELZ2 | 1.01e-04 | 303 | 150 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.29e-04 | 65 | 150 | 5 | GO:0070063 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX3 FOXS1 FOXN1 TCF4 HIVEP2 FOXN4 HMX3 ZBTB22 RELB SAMD7 PRDM4 TFAP4 HIVEP3 KMT2D SALL2 AEBP1 YLPM1 ZFHX2 SP5 SPDEF ZNF319 MNT SIX2 EPAS1 | 1.37e-04 | 1412 | 150 | 24 | GO:0000981 |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.38e-04 | 66 | 150 | 5 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.38e-04 | 66 | 150 | 5 | GO:0001098 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 2.05e-04 | 39 | 150 | 4 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 3.59e-04 | 45 | 150 | 4 | GO:0043175 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 5.52e-04 | 5 | 150 | 2 | GO:1990269 | |
| GeneOntologyMolecularFunction | SUMO polymer binding | 8.24e-04 | 6 | 150 | 2 | GO:0032184 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | SOX3 FOXN1 TCF4 HIVEP2 RELB PRDM4 TFAP4 KMT2D SALL2 ZNF319 SIX2 EPAS1 | 1.09e-03 | 560 | 150 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SHANK1 TRERF1 TCF4 URI1 ATN1 ANK3 MED14 ARID1A USP21 NCOR2 ARID1B KMT2D TCERG1 TLE1 TLE4 BRD4 MARK4 HELZ2 IRF2BPL | 1.13e-03 | 1160 | 150 | 19 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | SOX3 FOXN1 TCF4 HIVEP2 RELB PRDM4 TFAP4 KMT2D SALL2 ZNF319 SIX2 EPAS1 | 1.19e-03 | 566 | 150 | 12 | GO:0001216 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.52e-03 | 8 | 150 | 2 | GO:0140945 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 SOX3 FOXN1 TCF4 HIVEP2 TOX FOXN4 DVL1 MED14 RELB POGZ PRDM4 TFAP4 BPTF KMT2D SALL2 TCERG1 ATXN7 MICAL2 BRD4 HELZ2 MEPCE KMT2A SPDEF IRF2BPL ZNF319 AGRN SIX2 EPAS1 | 1.67e-07 | 1390 | 148 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TRERF1 SOX3 FOXS1 TCF4 URI1 ATN1 SCAF8 RELB SAMD7 ARID1A TFAP4 SCAF4 BPTF NCOR2 PHC3 ZNF469 SALL2 TCERG1 AEBP1 TLE1 TLE4 YLPM1 MEPCE SP5 SPDEF IRF2BPL CIPC MNT EPAS1 | 1.91e-07 | 1399 | 148 | 29 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TRERF1 SOX3 FOXS1 TCF4 URI1 ATN1 SCAF8 RELB SAMD7 ARID1A TFAP4 SCAF4 BPTF NCOR2 PHC3 ZNF469 SALL2 TCERG1 AEBP1 TLE1 TLE4 YLPM1 MEPCE SP5 SPDEF IRF2BPL CIPC MNT EPAS1 | 2.36e-07 | 1413 | 148 | 29 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX3 FOXS1 TCF4 URI1 ATN1 SCAF8 SAMD7 ARID1A SCAF4 BPTF NCOR2 ZNF469 SALL2 TCERG1 AEBP1 TLE1 TLE4 YLPM1 MEPCE SP5 SPDEF IRF2BPL MNT EPAS1 | 4.81e-07 | 1053 | 148 | 24 | GO:0000122 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | HSPG2 FOXN4 SOBP HMX3 DVL1 ARID1A SETD2 MICAL2 GNAS STRC SIX2 STRCP1 | 8.98e-06 | 351 | 148 | 12 | GO:0048562 |
| GeneOntologyBiologicalProcess | embryo development | TANC2 HSPG2 FRAT1 FOXN4 SOBP HMX3 DVL1 LAMA2 IFITM1 ARID1A INO80D BPTF NCOR2 SETD2 KMT2D SALL2 TJP1 MICAL2 BRD4 KMT2A GNAS STRC NOS3 SIX2 EPAS1 STRCP1 | 1.09e-05 | 1437 | 148 | 26 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryonic organ development | HSPG2 FOXN4 SOBP HMX3 DVL1 ARID1A BPTF SETD2 MICAL2 KMT2A GNAS STRC SIX2 EPAS1 STRCP1 | 1.29e-05 | 561 | 148 | 15 | GO:0048568 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | USP36 TTF2 TCF4 TOX BICRA MED14 POGZ SAMD7 HUWE1 ARID1A INO80D USP21 BPTF SETD2 ARID1B KMT2D BRD4 KMT2A GNAS BAHCC1 | 3.16e-05 | 999 | 148 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 5.11e-05 | 2 | 148 | 2 | GO:2000805 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription | 5.11e-05 | 2 | 148 | 2 | GO:0120191 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 1.53e-04 | 3 | 148 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription, poly(A)-coupled | 1.53e-04 | 3 | 148 | 2 | GO:0030846 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 1.53e-04 | 3 | 148 | 2 | GO:2000804 | |
| GeneOntologyBiologicalProcess | regulation of positive thymic T cell selection | 1.53e-04 | 3 | 148 | 2 | GO:1902232 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription | 1.89e-04 | 16 | 148 | 3 | GO:0006369 | |
| GeneOntologyBiologicalProcess | chromatin organization | USP36 TTF2 TOX BICRA SAMD7 HUWE1 ARID1A INO80D USP21 BPTF SETD2 ARID1B KMT2D BRD4 KMT2A GNAS BAHCC1 | 2.44e-04 | 896 | 148 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SOX3 FOXN1 HSPG2 FOXN4 SOBP HMX3 DVL1 LAMA2 SAMD7 ARID1A RYR1 NCOR2 SETD2 MICAL2 TLE1 SP5 GNAS STRC NOS3 SIX2 STRCP1 | 2.90e-04 | 1269 | 148 | 21 | GO:0009887 |
| GeneOntologyBiologicalProcess | chromatin remodeling | USP36 TTF2 BICRA SAMD7 HUWE1 ARID1A INO80D USP21 BPTF SETD2 ARID1B KMT2D BRD4 KMT2A GNAS | 2.92e-04 | 741 | 148 | 15 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 3.04e-04 | 4 | 148 | 2 | GO:1904594 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 TTF2 TCF4 SCAF8 BICRA MED14 POM121L2 RELB NUP214 SAMD7 ARID1A PRDM4 INO80D BPTF NCOR2 PHC3 ARID1B KMT2D CHMP4A ATXN7 TLE1 TLE4 BRD4 MEPCE KMT2A ACIN1 | 3.52e-06 | 1377 | 147 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | SOX3 FOXS1 FOXN1 TCF4 FOXN4 BICRA HMX3 ZBTB22 RELB POGZ ZNF385A ARID1A INO80D TFAP4 BPTF NCOR2 ARID1B ATXN7 BRD4 ZFHX2 SP5 SPDEF MNT SIX2 EPAS1 | 3.68e-05 | 1480 | 147 | 25 | GO:0000785 |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 9.25e-05 | 13 | 147 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.87e-04 | 96 | 147 | 5 | GO:0070603 | |
| HumanPheno | Long eyelashes | HSPG2 BICRA HECTD4 DVL1 ARID1A ARID1B KMT2D BRD4 KMT2A MAN1B1 | 5.92e-07 | 129 | 53 | 10 | HP:0000527 |
| HumanPheno | Abnormal nasal tip morphology | TCF4 ATN1 BICRA POGZ HUWE1 ARID1A RYR1 SCAF4 BPTF SETD2 ARID1B KMT2D KMT2A SIX2 MAN1B1 | 5.13e-06 | 386 | 53 | 15 | HP:0000436 |
| HumanPheno | Low hanging columella | 2.07e-05 | 56 | 53 | 6 | HP:0009765 | |
| HumanPheno | Broad nasal tip | 3.06e-05 | 159 | 53 | 9 | HP:0000455 | |
| HumanPheno | Short 5th finger | 4.49e-05 | 64 | 53 | 6 | HP:0009237 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 5.35e-05 | 66 | 53 | 6 | HP:0006262 | |
| HumanPheno | Abnormal columella morphology | 5.50e-05 | 97 | 53 | 7 | HP:0009929 | |
| HumanPheno | Congenital abnormal hair pattern | HSPG2 TCF4 BICRA HUWE1 ARID1A SETD2 ARID1B KMT2D AEBP1 BRD4 KMT2A MAN1B1 | 9.74e-05 | 327 | 53 | 12 | HP:0011361 |
| HumanPheno | Anteverted nares | TCF4 HIVEP2 BICRA DVL1 POGZ HUWE1 ARID1A RYR1 BPTF SETD2 ARID1B KMT2D BRD4 KMT2A CSPP1 SIX2 | 1.09e-04 | 559 | 53 | 16 | HP:0000463 |
| HumanPheno | Upturned nose | TCF4 HIVEP2 BICRA DVL1 POGZ HUWE1 ARID1A RYR1 BPTF SETD2 ARID1B KMT2D BRD4 KMT2A CSPP1 SIX2 | 1.09e-04 | 559 | 53 | 16 | HP:0000427 |
| HumanPheno | Prominent digit pad | 1.23e-04 | 48 | 53 | 5 | HP:0011298 | |
| HumanPheno | Delayed speech and language development | TANC2 HSPG2 TCF4 HIVEP2 ATN1 ANK3 SOBP POGZ HUWE1 ARID1A RYR1 SCAF4 DNAH1 BPTF SETD2 ARID1B KMT2D BRD4 MAST1 KMT2A IRF2BPL GNAS CSPP1 HYDIN | 1.33e-04 | 1123 | 53 | 24 | HP:0000750 |
| HumanPheno | Abnormal neck morphology | HSPG2 TCF4 ATN1 HECTD4 DVL1 LAMA2 POGZ HUWE1 RYR1 BPTF KMT2D THPO AEBP1 BRD4 KMT2A GNAS CSPP1 AGRN MAN1B1 | 1.40e-04 | 766 | 53 | 19 | HP:0025668 |
| HumanPheno | Abnormal nostril morphology | TCF4 HIVEP2 BICRA DVL1 POGZ HUWE1 ARID1A RYR1 BPTF SETD2 ARID1B KMT2D BRD4 KMT2A CSPP1 SIX2 | 1.53e-04 | 575 | 53 | 16 | HP:0005288 |
| HumanPheno | Abnormal nasal septum morphology | 1.63e-04 | 115 | 53 | 7 | HP:0000419 | |
| HumanPheno | Gastroesophageal reflux | HSPG2 TCF4 HIVEP2 ATN1 BICRA HECTD4 LAMA2 NUP214 POGZ KMT2D BRD4 KMT2A GNAS CSPP1 AGRN | 1.65e-04 | 517 | 53 | 15 | HP:0002020 |
| HumanPheno | Abnormal external nose morphology | SOX3 HSPG2 TCF4 HIVEP2 ATN1 BICRA DVL1 POGZ HUWE1 ARID1A RYR1 SCAF4 BPTF SETD2 ARID1B KMT2D BRD4 KMT2A CSPP1 SIX2 MAN1B1 | 1.67e-04 | 916 | 53 | 21 | HP:0010938 |
| HumanPheno | Abnormality of the neck | HSPG2 TCF4 ATN1 HECTD4 DVL1 LAMA2 POGZ HUWE1 RYR1 DNAH1 BPTF KMT2D THPO AEBP1 BRD4 KMT2A GNAS CSPP1 AGRN MAN1B1 | 2.07e-04 | 858 | 53 | 20 | HP:0000464 |
| HumanPheno | Short philtrum | TCF4 HIVEP2 HECTD4 DVL1 POGZ HUWE1 ARID1A BPTF ARID1B MAN1B1 | 2.24e-04 | 253 | 53 | 10 | HP:0000322 |
| HumanPheno | Small hand | 2.35e-04 | 122 | 53 | 7 | HP:0200055 | |
| HumanPheno | Language impairment | TANC2 HSPG2 TCF4 HIVEP2 ATN1 ANK3 SOBP POGZ HUWE1 ARID1A RYR1 SCAF4 DNAH1 BPTF SETD2 ARID1B KMT2D BRD4 MAST1 KMT2A IRF2BPL GNAS CSPP1 HYDIN | 2.91e-04 | 1178 | 53 | 24 | HP:0002463 |
| HumanPheno | Abnormal eating behavior | 3.16e-04 | 128 | 53 | 7 | HP:0100738 | |
| HumanPheno | Autistic behavior | SOX3 TANC2 HSPG2 TCF4 HIVEP2 ANK3 BICRA HECTD4 POGZ ARID1A SCAF4 SETD2 ARID1B KMT2D BRD4 KMT2A MAN1B1 | 3.20e-04 | 678 | 53 | 17 | HP:0000729 |
| HumanPheno | Hirsutism | 3.26e-04 | 216 | 53 | 9 | HP:0001007 | |
| HumanPheno | Increased body weight | SOX3 HSPG2 ANK3 HECTD4 PCARE POGZ RYR1 SCAF4 BPTF SETD2 KMT2D BRD4 GNAS MAN1B1 | 3.47e-04 | 491 | 53 | 14 | HP:0004324 |
| HumanPheno | Joint hypermobility | TANC2 ATN1 SOBP BICRA POGZ ARID1A RYR1 SCAF4 ZNF469 ARID1B KMT2D AEBP1 KMT2A AGRN MAN1B1 | 3.76e-04 | 557 | 53 | 15 | HP:0001382 |
| HumanPheno | Scoliosis | TANC2 HSPG2 TCF4 ATN1 BICRA HECTD4 DVL1 LAMA2 HUWE1 ARID1A RYR1 SCAF4 BPTF ZNF469 ARID1B KMT2D THPO AEBP1 BRD4 KMT2A GNAS CSPP1 AGRN | 3.90e-04 | 1122 | 53 | 23 | HP:0002650 |
| MousePheno | muscle spasm | 1.67e-05 | 60 | 127 | 6 | MP:0000743 | |
| MousePheno | decreased prepulse inhibition | TANC2 TCF4 HIVEP2 TOX FOXN4 DVL1 PATL1 ASIC3 BPTF SETD2 ARID1B SRGAP3 MICAL2 TLE4 BRD4 | 2.01e-05 | 464 | 127 | 15 | MP:0009142 |
| MousePheno | muscle twitch | 2.43e-05 | 64 | 127 | 6 | MP:0009046 | |
| MousePheno | abnormal synaptic transmission | SHANK1 TANC2 HSPG2 TCF4 HIVEP2 TOX FOXN4 DVL1 LAMA2 POGZ PATL1 ASIC3 BPTF SETD2 ARID1B ATXN7 SRGAP3 MICAL2 TLE4 BRD4 AGRN NOS3 PHF21B | 8.63e-05 | 1070 | 127 | 23 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | SHANK1 TANC2 HSPG2 TCF4 HIVEP2 TOX FOXN4 DVL1 LAMA2 POGZ PATL1 ASIC3 BPTF SETD2 ARID1B ATXN7 SRGAP3 MICAL2 TLE4 BRD4 AGRN NOS3 PHF21B | 9.40e-05 | 1076 | 127 | 23 | MP:0021009 |
| Domain | BAF250/Osa | 5.99e-05 | 2 | 145 | 2 | IPR021906 | |
| Domain | BAF250_C | 5.99e-05 | 2 | 145 | 2 | IPR033388 | |
| Domain | BAF250_C | 5.99e-05 | 2 | 145 | 2 | PF12031 | |
| Domain | Laminin_G_1 | 7.23e-05 | 11 | 145 | 3 | PF00054 | |
| Domain | Post-SET_dom | 2.38e-04 | 16 | 145 | 3 | IPR003616 | |
| Domain | PostSET | 2.38e-04 | 16 | 145 | 3 | SM00508 | |
| Domain | POST_SET | 2.38e-04 | 16 | 145 | 3 | PS50868 | |
| Domain | DUF1908 | 3.56e-04 | 4 | 145 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 3.56e-04 | 4 | 145 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 3.56e-04 | 4 | 145 | 2 | IPR023142 | |
| Domain | - | 3.56e-04 | 4 | 145 | 2 | 1.20.1480.20 | |
| Domain | SET | 4.41e-04 | 46 | 145 | 4 | SM00317 | |
| Domain | FYrich_C | 5.89e-04 | 5 | 145 | 2 | IPR003889 | |
| Domain | FYrich_N | 5.89e-04 | 5 | 145 | 2 | IPR003888 | |
| Domain | NUT | 5.89e-04 | 5 | 145 | 2 | IPR024310 | |
| Domain | NUT_N | 5.89e-04 | 5 | 145 | 2 | IPR024309 | |
| Domain | FYRC | 5.89e-04 | 5 | 145 | 2 | SM00542 | |
| Domain | FYRN | 5.89e-04 | 5 | 145 | 2 | SM00541 | |
| Domain | Groucho_enhance | 5.89e-04 | 5 | 145 | 2 | IPR009146 | |
| Domain | TLE_N | 5.89e-04 | 5 | 145 | 2 | PF03920 | |
| Domain | NUT | 5.89e-04 | 5 | 145 | 2 | PF12881 | |
| Domain | Groucho/TLE_N | 5.89e-04 | 5 | 145 | 2 | IPR005617 | |
| Domain | FYRN | 5.89e-04 | 5 | 145 | 2 | PF05964 | |
| Domain | FYRC | 5.89e-04 | 5 | 145 | 2 | PF05965 | |
| Domain | FYRC | 5.89e-04 | 5 | 145 | 2 | PS51543 | |
| Domain | FYRN | 5.89e-04 | 5 | 145 | 2 | PS51542 | |
| Domain | SET_dom | 6.08e-04 | 50 | 145 | 4 | IPR001214 | |
| Domain | SET | 6.08e-04 | 50 | 145 | 4 | PS50280 | |
| Domain | PDZ | 8.19e-04 | 141 | 145 | 6 | PF00595 | |
| Domain | FAD-bd | 8.80e-04 | 6 | 145 | 2 | IPR002938 | |
| Domain | ZF_FCS | 8.80e-04 | 6 | 145 | 2 | PS51024 | |
| Domain | FAD_binding_3 | 8.80e-04 | 6 | 145 | 2 | PF01494 | |
| Domain | PDZ | 1.05e-03 | 148 | 145 | 6 | SM00228 | |
| Domain | - | 1.13e-03 | 150 | 145 | 6 | 2.30.42.10 | |
| Domain | PDZ | 1.17e-03 | 151 | 145 | 6 | PS50106 | |
| Domain | PDZ | 1.21e-03 | 152 | 145 | 6 | IPR001478 | |
| Domain | RNA_pol_II-bd | 1.23e-03 | 7 | 145 | 2 | IPR006903 | |
| Domain | CTD_bind | 1.23e-03 | 7 | 145 | 2 | PF04818 | |
| Domain | - | 1.42e-03 | 106 | 145 | 5 | 1.10.150.50 | |
| Domain | EGF_LAM_2 | 1.60e-03 | 30 | 145 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.60e-03 | 30 | 145 | 3 | PS01248 | |
| Domain | RPR | 1.63e-03 | 8 | 145 | 2 | SM00582 | |
| Domain | CID_dom | 1.63e-03 | 8 | 145 | 2 | IPR006569 | |
| Domain | CID | 1.63e-03 | 8 | 145 | 2 | PS51391 | |
| Domain | LAMININ_IVA | 1.63e-03 | 8 | 145 | 2 | PS51115 | |
| Domain | Laminin_B | 1.63e-03 | 8 | 145 | 2 | PF00052 | |
| Domain | LamB | 1.63e-03 | 8 | 145 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.63e-03 | 8 | 145 | 2 | IPR000034 | |
| Domain | SAM_1 | 1.93e-03 | 68 | 145 | 4 | PF00536 | |
| Domain | ZU5 | 2.08e-03 | 9 | 145 | 2 | SM00218 | |
| Domain | SAM/pointed | 2.20e-03 | 117 | 145 | 5 | IPR013761 | |
| Domain | EGF_Lam | 2.50e-03 | 35 | 145 | 3 | SM00180 | |
| Domain | Laminin_EGF | 2.50e-03 | 35 | 145 | 3 | PF00053 | |
| Domain | ZU5 | 2.59e-03 | 10 | 145 | 2 | PS51145 | |
| Domain | EGF_CA | 2.64e-03 | 122 | 145 | 5 | SM00179 | |
| Domain | PHD | 2.76e-03 | 75 | 145 | 4 | PF00628 | |
| Domain | EGF-like_Ca-bd_dom | 2.83e-03 | 124 | 145 | 5 | IPR001881 | |
| Domain | EGF | 3.03e-03 | 126 | 145 | 5 | PF00008 | |
| Domain | LAM_G_DOMAIN | 3.17e-03 | 38 | 145 | 3 | PS50025 | |
| Domain | Laminin_EGF | 3.17e-03 | 38 | 145 | 3 | IPR002049 | |
| Domain | Znf_PHD-finger | 3.34e-03 | 79 | 145 | 4 | IPR019787 | |
| Domain | Znf_C2H2-like | TRERF1 HIVEP2 ZBTB22 POGZ ZNF385A PRDM4 HIVEP3 ZNF469 SALL2 ATXN7 HELZ2 ZFHX2 SP5 ZNF319 | 3.64e-03 | 796 | 145 | 14 | IPR015880 |
| Domain | ZU5 | 3.75e-03 | 12 | 145 | 2 | PF00791 | |
| Domain | ZU5_dom | 3.75e-03 | 12 | 145 | 2 | IPR000906 | |
| Domain | SET | 3.94e-03 | 41 | 145 | 3 | PF00856 | |
| Domain | BROMODOMAIN_2 | 3.94e-03 | 41 | 145 | 3 | PS50014 | |
| Domain | ZnF_C2H2 | TRERF1 HIVEP2 ZBTB22 POGZ ZNF385A PRDM4 HIVEP3 ZNF469 SALL2 ATXN7 HELZ2 ZFHX2 SP5 ZNF319 | 4.15e-03 | 808 | 145 | 14 | SM00355 |
| Domain | Bromodomain | 4.22e-03 | 42 | 145 | 3 | IPR001487 | |
| Domain | BROMO | 4.22e-03 | 42 | 145 | 3 | SM00297 | |
| Domain | - | 4.22e-03 | 42 | 145 | 3 | 1.20.920.10 | |
| Domain | LamG | 4.81e-03 | 44 | 145 | 3 | SM00282 | |
| Domain | SAM | 4.91e-03 | 88 | 145 | 4 | SM00454 | |
| Domain | PHD | 5.11e-03 | 89 | 145 | 4 | SM00249 | |
| Domain | Dynein_HC_stalk | 5.12e-03 | 14 | 145 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.12e-03 | 14 | 145 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.12e-03 | 14 | 145 | 2 | PF08393 | |
| Domain | SEA | 5.12e-03 | 14 | 145 | 2 | SM00200 | |
| Domain | MT | 5.12e-03 | 14 | 145 | 2 | PF12777 | |
| Domain | TF_fork_head_CS_2 | 5.45e-03 | 46 | 145 | 3 | IPR030456 | |
| Domain | Znf_PHD | 5.53e-03 | 91 | 145 | 4 | IPR001965 | |
| Domain | TF_fork_head_CS_1 | 5.79e-03 | 47 | 145 | 3 | IPR018122 | |
| Domain | DHC_fam | 5.88e-03 | 15 | 145 | 2 | IPR026983 | |
| Domain | - | 5.88e-03 | 15 | 145 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 5.88e-03 | 15 | 145 | 2 | SM00501 | |
| Domain | ARID_dom | 5.88e-03 | 15 | 145 | 2 | IPR001606 | |
| Domain | ARID | 5.88e-03 | 15 | 145 | 2 | PS51011 | |
| Domain | Dynein_heavy | 5.88e-03 | 15 | 145 | 2 | PF03028 | |
| Domain | ARID | 5.88e-03 | 15 | 145 | 2 | PF01388 | |
| Domain | Dynein_heavy_dom | 5.88e-03 | 15 | 145 | 2 | IPR004273 | |
| Domain | SAM_DOMAIN | 6.43e-03 | 95 | 145 | 4 | PS50105 | |
| Domain | ZF_PHD_2 | 6.43e-03 | 95 | 145 | 4 | PS50016 | |
| Domain | FH | 6.50e-03 | 49 | 145 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 6.50e-03 | 49 | 145 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 6.50e-03 | 49 | 145 | 3 | PS00658 | |
| Domain | Fork_head_dom | 6.50e-03 | 49 | 145 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 6.50e-03 | 49 | 145 | 3 | PS50039 | |
| Domain | Forkhead | 6.50e-03 | 49 | 145 | 3 | PF00250 | |
| Domain | ZF_PHD_1 | 6.67e-03 | 96 | 145 | 4 | PS01359 | |
| Domain | SAM | 6.91e-03 | 97 | 145 | 4 | IPR001660 | |
| Domain | ZINC_FINGER_C2H2_2 | TRERF1 HIVEP2 ZBTB22 POGZ ZNF385A PRDM4 HIVEP3 ZNF469 SALL2 HELZ2 ZFHX2 SP5 ZNF319 | 7.40e-03 | 775 | 145 | 13 | PS50157 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 HSPG2 CRYBG2 HIVEP2 BICRA HECTD4 DVL1 MED14 RELB NUP214 SFI1 HUWE1 MBD6 ARID1A RYR1 TBC1D17 GGT7 HIVEP3 NCOR2 ARHGEF40 KMT2D ADAMTS7 BRD4 MARK4 SEC16A HELZ2 MICAL3 AGRN CEP170B PKN3 BAHCC1 AGAP3 | 1.78e-17 | 1105 | 153 | 32 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 ABCF1 ATN1 SCAF8 MED14 NUP214 POGZ PATL1 HUWE1 TFAP4 SCAF4 BPTF NCOR2 PHC3 SETD2 KMT2D ATXN7 TLE4 BRD4 YLPM1 SEC16A HELZ2 KMT2A ACIN1 IRF2BPL MICAL3 | 8.23e-16 | 774 | 153 | 26 | 15302935 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 HIVEP2 ATN1 SOBP BICRA NUP214 POGZ MBD6 ARID1A TFAP4 BPTF NCOR2 ARID1B KMT2D TLE1 TLE4 SEC16A KMT2A BAHCC1 | 1.78e-15 | 351 | 153 | 19 | 38297188 |
| Pubmed | TRERF1 HSPG2 TCF4 ATN1 SOBP SCAF8 BICRA RELB NUP214 POGZ PATL1 MAP7 MBD6 ARID1A INO80D TFAP4 SCAF4 BPTF NCOR2 PHC3 ARID1B KMT2D SALL2 TCERG1 ATXN7 TLE1 TLE4 YLPM1 SEC16A KMT2A IRF2BPL ZNF319 MNT | 3.67e-15 | 1429 | 153 | 33 | 35140242 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | URI1 HIVEP2 ANK3 SOBP SCAF8 BICRA WASF3 HECTD4 PATL1 ZNF385A HUWE1 ARID1A MAP3K12 TFAP4 DNAH1 KLHL29 HIVEP3 BPTF NCOR2 TJP1 FAM120C ATXN7 MICAL2 NECTIN2 MAST1 ZFHX2 MICAL3 GNAS CEP170B MAN1B1 AGAP3 | 4.41e-13 | 1489 | 153 | 31 | 28611215 |
| Pubmed | TCF4 HIVEP2 TOX FOXN4 HMX3 ZBTB22 RELB POGZ ARID1A PRDM4 ZFAND4 TFAP4 LDB3 SALL2 BRD4 ZFHX2 KMT2A SPDEF MNT SIX2 EPAS1 RNF111 | 8.01e-13 | 709 | 153 | 22 | 22988430 | |
| Pubmed | TTF2 ANK3 DVL1 MED14 POGZ HUWE1 ARID1A SCAF4 BPTF SETD2 ARID1B KMT2D TCERG1 TJP1 BRD4 YLPM1 SEC16A KMT2A ACIN1 | 5.03e-12 | 549 | 153 | 19 | 38280479 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TRERF1 ATN1 ANK3 BICRA INPP5D RELB NUP214 PRDM4 PRR7 ASAP1 NCOR2 PHC3 ZNF469 AEBP1 YLPM1 IRF2BPL NYAP1 | 8.93e-12 | 430 | 153 | 17 | 35044719 |
| Pubmed | SCAF8 NUP214 POGZ RNF157 ASAP1 KLHL29 SRGAP3 TLE4 MARK4 SEC16A MAST1 ACIN1 CIPC MICAL3 ZNF319 CEP170B | 4.10e-11 | 407 | 153 | 16 | 12693553 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TRERF1 SOX3 FOXS1 FOXN1 TCF4 HIVEP2 FOXN4 HMX3 RELB ZNF385A PRDM4 TFAP4 HIVEP3 KMT2D SALL2 ZFHX2 SP5 KMT2A SPDEF MNT SIX2 EPAS1 | 9.59e-11 | 908 | 153 | 22 | 19274049 |
| Pubmed | USP36 TANC2 ATN1 BICRA POGZ MAP7 ARID1A INO80D BPTF NCOR2 SETD2 ZNF469 ARID1B ARHGEF40 SALL2 FAM120C ATXN7 BRD4 MARK4 SEC16A MEPCE CEP170B BAHCC1 AGAP3 | 1.41e-10 | 1116 | 153 | 24 | 31753913 | |
| Pubmed | TRERF1 ATN1 MED14 ARID1A ARID1B KMT2D TLE1 TLE4 BRD4 YLPM1 MEPCE KMT2A | 2.89e-09 | 268 | 153 | 12 | 33640491 | |
| Pubmed | TRERF1 SOX3 TCF4 URI1 TOX ZBTB22 POGZ ZNF385A ARID1A PRDM4 TFAP4 HIVEP3 BPTF KRBA1 BRD4 ACIN1 SPDEF MNT EPAS1 | 3.29e-09 | 808 | 153 | 19 | 20412781 | |
| Pubmed | 3.48e-09 | 83 | 153 | 8 | 28794006 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TTF2 BICRA POGZ ARID1A NCOR2 PHC3 ARID1B KMT2D TLE1 BRD4 SEC16A NUTM2F BAHCC1 | 2.68e-08 | 398 | 153 | 13 | 35016035 |
| Pubmed | TRERF1 DVL1 NUP214 POGZ HUWE1 NCOR2 PHC3 KMT2D SALL2 TLE1 TLE4 BRD4 SEC16A | 4.75e-08 | 418 | 153 | 13 | 34709266 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 HIVEP2 MAP7 MAST4 FAM171A2 TCERG1 TJP1 BRD4 NECTIN2 MARK4 SEC16A MEPCE KMT2A GNAS CSPP1 CEP170B BICC1 AGAP3 | 5.23e-08 | 861 | 153 | 18 | 36931259 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | USP36 TTF2 NUP214 POGZ MAP7 ARID1A INO80D TFAP4 SCAF4 BPTF NCOR2 PHC3 SETD2 KMT2D TCERG1 BRD4 YLPM1 KMT2A ACIN1 ZNF319 MNT SIX2 | 6.05e-08 | 1294 | 153 | 22 | 30804502 |
| Pubmed | 1.73e-07 | 12 | 153 | 4 | 16750824 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 BICRA NUP214 POGZ ARID1A SCAF4 BPTF NCOR2 PHC3 SETD2 ARID1B TCERG1 TJP1 BRD4 YLPM1 SEC16A KMT2A ACIN1 | 2.38e-07 | 954 | 153 | 18 | 36373674 |
| Pubmed | ABCF1 ANK3 SCAF8 IFITM1 NUP214 HUWE1 TFAP4 TCERG1 BRD4 MEPCE ACIN1 MICAL3 | 2.53e-07 | 403 | 153 | 12 | 35253629 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TANC2 TTF2 SCAF8 SFI1 HUWE1 MAP7 ARID1A SEC31B NCOR2 FAM120C BRD4 YLPM1 ACIN1 GNAS | 3.29e-07 | 582 | 153 | 14 | 20467437 |
| Pubmed | TTF2 HSPG2 ANK3 HUWE1 PRDM4 NCOR2 ARID1B KMT2D MAST4 BRD4 YLPM1 NID1 EPAS1 RNF111 | 3.96e-07 | 591 | 153 | 14 | 15231748 | |
| Pubmed | TRERF1 TTF2 ABCF1 BICRA INPP5D MED14 POGZ ARID1A INO80D TFAP4 SCAF4 BPTF NCOR2 ARID1B KMT2D TCERG1 BRD4 KMT2A MNT | 4.30e-07 | 1103 | 153 | 19 | 34189442 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 6.26e-07 | 69 | 153 | 6 | 28481362 | |
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 6.29e-07 | 16 | 153 | 4 | 17948866 | |
| Pubmed | 6.29e-07 | 16 | 153 | 4 | 11564885 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 7670489 | ||
| Pubmed | SHANK1 TRERF1 TANC2 SGIP1 ANK3 HECTD4 ZBTB22 HUWE1 NCOR2 FAM171A2 TJP1 FAM120C SRGAP3 YLPM1 SEC16A AGRN CEP170B | 1.31e-06 | 963 | 153 | 17 | 28671696 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXS1 FOXN1 TTF2 TCF4 RELB POGZ HUWE1 TFAP4 BPTF NCOR2 KMT2D SALL2 TCERG1 TLE1 TLE4 MNT | 1.33e-06 | 857 | 153 | 16 | 25609649 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CELF5 ABCF1 ANK3 NUP214 SCAF4 KRBA1 MEPCE KMT2A NID1 MICAL3 CSPP1 HYDIN | 2.27e-06 | 497 | 153 | 12 | 36774506 |
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 19219072 | ||
| Pubmed | Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. | 2.88e-06 | 7 | 153 | 3 | 11802174 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | MED14 POGZ ARID1A BPTF ARID1B KMT2D FAM120C YLPM1 KMT2A ACIN1 | 2.99e-06 | 341 | 153 | 10 | 32971831 |
| Pubmed | USP36 URI1 ANK3 HUWE1 ARID1A ASAP1 NCOR2 ARID1B KMT2D FAM171A2 TJP1 NECTIN2 YLPM1 SEC16A MICAL3 CSPP1 SIX2 | 4.10e-06 | 1049 | 153 | 17 | 27880917 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | URI1 ABCF1 BICRA MED14 POGZ ARID1A BPTF PHC3 TCERG1 BRD4 KMT2A ACIN1 | 4.64e-06 | 533 | 153 | 12 | 30554943 |
| Pubmed | 5.37e-06 | 57 | 153 | 5 | 38223760 | ||
| Pubmed | 5.84e-06 | 27 | 153 | 4 | 29374058 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ABCF1 HECTD4 MED14 POGZ ARID1A SCAF4 BPTF SETD2 ARID1B TCERG1 TJP1 BRD4 YLPM1 HELZ2 ACIN1 AGRN PLXNB1 | 6.16e-06 | 1082 | 153 | 17 | 38697112 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | ATN1 SCAF8 NUP214 ARID1A NCOR2 ARID1B KMT2D TLE1 YLPM1 SEC16A BICC1 | 6.27e-06 | 457 | 153 | 11 | 32344865 |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 9.50e-06 | 307 | 153 | 9 | 37499664 | |
| Pubmed | 9.79e-06 | 10 | 153 | 3 | 12665591 | ||
| Pubmed | SHANK1 HIVEP2 ANK3 BICRA NUP214 POGZ ASAP1 KIAA1549L TCERG1 EPAS1 RNF111 | 1.11e-05 | 486 | 153 | 11 | 20936779 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | HIVEP2 ATN1 TROAP POGZ MBD6 INO80D BPTF PHC3 KMT2D KMT2A MNT | 1.32e-05 | 495 | 153 | 11 | 27705803 |
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 1.34e-05 | 11 | 153 | 3 | 17023412 | |
| Pubmed | SHANK1 ABCF1 HIVEP2 ANK3 HECTD4 POGZ HUWE1 ARID1A PRDM4 SEC31B TCERG1 TJP1 MICAL2 YLPM1 MAST1 CIPC RNF111 AGAP3 | 1.53e-05 | 1285 | 153 | 18 | 35914814 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | USP36 TTF2 ABCF1 NUP214 SCAF4 PHC3 SETD2 TCERG1 TJP1 YLPM1 SEC16A MEPCE KMT2A ACIN1 PKN3 | 1.73e-05 | 934 | 153 | 15 | 33916271 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.83e-05 | 184 | 153 | 7 | 32908313 | |
| Pubmed | Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma. | 1.92e-05 | 2 | 153 | 2 | 25506919 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 21512133 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 35715442 | ||
| Pubmed | SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia. | 1.92e-05 | 2 | 153 | 2 | 29249820 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 20404140 | ||
| Pubmed | MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. | 1.92e-05 | 2 | 153 | 2 | 29777171 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 9572356 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 1.92e-05 | 2 | 153 | 2 | 37611161 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 32791957 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 31104839 | ||
| Pubmed | Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo. | 1.92e-05 | 2 | 153 | 2 | 26711341 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 16103356 | ||
| Pubmed | A new mouse model for autosomal recessive polycystic kidney disease. | 1.92e-05 | 2 | 153 | 2 | 11944981 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 34910522 | ||
| Pubmed | Crystal structure and mutational analysis of a perlecan-binding fragment of nidogen-1. | 1.92e-05 | 2 | 153 | 2 | 11427896 | |
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 1.92e-05 | 2 | 153 | 2 | 28967863 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24423662 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 11574465 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 34386776 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 23202128 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 33890484 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 11687802 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 1.92e-05 | 2 | 153 | 2 | 24562383 | |
| Pubmed | Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin. | 1.92e-05 | 2 | 153 | 2 | 19020093 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 27846392 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 1.92e-05 | 2 | 153 | 2 | 29890703 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 35218185 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24788099 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 33052929 | ||
| Pubmed | Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties. | 1.92e-05 | 2 | 153 | 2 | 2247438 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 32312818 | ||
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 1.92e-05 | 2 | 153 | 2 | 27562491 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | HSPG2 ATN1 CD248 IFITM1 ARID1A NCOR2 TCERG1 AEBP1 TJP1 FAM120C TLE1 BRD4 SEC16A MEPCE NID1 GNAS AGRN MNT MAN1B1 | 2.22e-05 | 1451 | 153 | 19 | 30550785 |
| Pubmed | 2.31e-05 | 13 | 153 | 3 | 12682087 | ||
| Pubmed | 2.31e-05 | 263 | 153 | 8 | 20932939 | ||
| Pubmed | PIK3AP1 SCAF8 NUP214 PATL1 HUWE1 GGT7 SETD2 ARID1B TJP1 TLE1 YLPM1 SEC16A PKN3 | 2.34e-05 | 733 | 153 | 13 | 34672954 | |
| Pubmed | 2.51e-05 | 78 | 153 | 5 | 28611094 | ||
| Pubmed | 2.63e-05 | 39 | 153 | 4 | 21909109 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PIK3AP1 TTF2 ABCF1 TROAP FPGS BSDC1 PATL1 ASAP1 MAST4 TJP1 MICAL3 MINDY4 AGRN CEP170B | 2.64e-05 | 853 | 153 | 14 | 28718761 |
| Pubmed | BSDC1 LAMA2 NCOR2 TJP1 NECTIN2 SP5 NID1 MICAL3 GNAS AGRN MNT CEP170B PSRC1 PHF21B PKN3 CFAP46 RNF111 | 2.72e-05 | 1215 | 153 | 17 | 15146197 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ABCF1 HECTD4 MED14 NUP214 HUWE1 ARID1A SETD2 ARID1B YLPM1 SEC16A | 2.73e-05 | 440 | 153 | 10 | 34244565 |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 2.91e-05 | 40 | 153 | 4 | 34585037 | |
| Pubmed | Deletion of astroglial connexins weakens the blood-brain barrier. | 2.93e-05 | 14 | 153 | 3 | 22472609 | |
| Pubmed | ABCF1 ATN1 SCAF8 PATL1 TBC1D17 ARHGEF40 TCERG1 KMT2A MICAL3 AGRN PLXNB1 MAN1B1 | 3.31e-05 | 650 | 153 | 12 | 38777146 | |
| Pubmed | USP36 ABCF1 SCAF8 MED14 ZNF385A MAP7 INO80D SCAF4 PHC3 SETD2 TCERG1 FAM120C ATXN7 HELZ2 KMT2A AGRN CEP170B MAN1B1 AGAP3 | 3.40e-05 | 1497 | 153 | 19 | 31527615 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.43e-05 | 203 | 153 | 7 | 22083510 | |
| Pubmed | ABCF1 NUP214 POGZ HUWE1 ARID1A BPTF TJP1 YLPM1 SEC16A HELZ2 KMT2A ACIN1 | 3.46e-05 | 653 | 153 | 12 | 22586326 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ATN1 ZCCHC2 RYR1 KLHL29 KMT2D TJP1 HELZ2 ZFHX2 MICAL3 GNAS PSRC1 | 3.58e-05 | 552 | 153 | 11 | 10737800 |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 3.65e-05 | 15 | 153 | 3 | 15895400 | |
| Pubmed | SHANK1 TANC2 ABCF1 SGIP1 ANK3 DVL1 BSDC1 HUWE1 ASAP1 GGT7 FAM171A2 TJP1 FAM120C SRGAP3 CEP170B AGAP3 | 4.53e-05 | 1139 | 153 | 16 | 36417873 | |
| Pubmed | CRYBG2 NUP214 HUWE1 ARID1A BPTF KMT2D BRD4 KMT2A ACIN1 HYDIN | 4.66e-05 | 469 | 153 | 10 | 27634302 | |
| Pubmed | USP36 TTF2 ARID1A ASAP1 SCAF4 BPTF ARID1B NECTIN2 SEC16A IRF2BPL | 4.92e-05 | 472 | 153 | 10 | 38943005 | |
| Interaction | TLE3 interactions | TRERF1 TCF4 HIVEP2 ATN1 ANK3 SCAF8 ARID1A INO80D SCAF4 NCOR2 PHC3 SETD2 ARID1B KMT2D TLE1 TLE4 BRD4 KMT2A SIX2 | 4.20e-11 | 376 | 148 | 19 | int:TLE3 |
| Interaction | TOP3B interactions | TANC2 HSPG2 CRYBG2 HIVEP2 BICRA HECTD4 DVL1 MED14 RELB NUP214 SFI1 PATL1 HUWE1 MBD6 ARID1A RYR1 TBC1D17 GGT7 HIVEP3 NCOR2 ARHGEF40 KMT2D ADAMTS7 FAM120C BRD4 MARK4 SEC16A HELZ2 ACIN1 MICAL3 GNAS AGRN CEP170B PKN3 BAHCC1 AGAP3 | 8.74e-11 | 1470 | 148 | 36 | int:TOP3B |
| Interaction | EGR2 interactions | TRERF1 HIVEP2 ATN1 BICRA POGZ ARID1A NCOR2 ARID1B KMT2D TLE1 SEC16A KMT2A BAHCC1 | 4.22e-10 | 171 | 148 | 13 | int:EGR2 |
| Interaction | CRX interactions | TRERF1 SOX3 ATN1 BICRA POGZ SFI1 ARID1A TFAP4 NCOR2 ARID1B KMT2D ATXN7 TLE1 BAHCC1 | 5.86e-09 | 254 | 148 | 14 | int:CRX |
| Interaction | SP7 interactions | TRERF1 ATN1 SCAF8 BICRA POGZ ARID1A SCAF4 NCOR2 ARID1B KMT2D TCERG1 TLE1 TLE4 YLPM1 | 5.63e-08 | 304 | 148 | 14 | int:SP7 |
| Interaction | GSC interactions | 2.50e-07 | 87 | 148 | 8 | int:GSC | |
| Interaction | NCK2 interactions | PIK3AP1 TCF4 ATN1 WASF3 DVL1 MBD6 ASAP1 YLPM1 CIPC NUTM2F FYB1 MNT | 5.53e-07 | 262 | 148 | 12 | int:NCK2 |
| Interaction | ETV4 interactions | 7.37e-07 | 69 | 148 | 7 | int:ETV4 | |
| Interaction | NFIX interactions | FOXN1 BICRA POGZ ARID1A TFAP4 BPTF NCOR2 ARID1B KMT2D TLE1 KMT2A | 9.61e-07 | 227 | 148 | 11 | int:NFIX |
| Interaction | ALG13 interactions | USP36 ATN1 SCAF8 ARID1A NCOR2 ARID1B KMT2D FAM120C TLE1 SEC16A | 1.03e-06 | 183 | 148 | 10 | int:ALG13 |
| Interaction | SMARCC2 interactions | FOXN1 TCF4 BICRA RELB ARID1A TFAP4 ARID1B SRGAP3 BRD4 YLPM1 MEPCE KMT2A EPAS1 | 2.13e-06 | 353 | 148 | 13 | int:SMARCC2 |
| Interaction | TBXT interactions | 2.28e-06 | 116 | 148 | 8 | int:TBXT | |
| Interaction | E2F4 interactions | ABCF1 ANK3 SCAF8 IFITM1 NUP214 HUWE1 ARID1A TFAP4 NCOR2 ARID1B TCERG1 BRD4 MEPCE KMT2A ACIN1 MICAL3 | 2.38e-06 | 540 | 148 | 16 | int:E2F4 |
| Interaction | FEV interactions | 2.63e-06 | 203 | 148 | 10 | int:FEV | |
| Interaction | WWTR1 interactions | TTF2 ANK3 DVL1 POGZ ARID1A BPTF SETD2 ARID1B KMT2D TCERG1 TJP1 BRD4 SEC16A KMT2A | 2.89e-06 | 422 | 148 | 14 | int:WWTR1 |
| Interaction | AR interactions | TRERF1 TCF4 ATN1 HECTD4 MED14 HUWE1 ARID1A NCOR2 ARID1B KMT2D TJP1 TLE1 TLE4 BRD4 YLPM1 SEC16A MEPCE KMT2A ACIN1 SPDEF IRF2BPL GNAS | 3.47e-06 | 992 | 148 | 22 | int:AR |
| Interaction | SMG7 interactions | SCAF8 PATL1 ARID1A NCOR2 ARID1B KMT2D SALL2 FAM120C TLE1 TLE4 YLPM1 SEC16A | 4.30e-06 | 319 | 148 | 12 | int:SMG7 |
| Interaction | SNRNP40 interactions | USP36 HSPG2 ATN1 SCAF8 DVL1 POGZ ARID1A SCAF4 NCOR2 PHC3 SETD2 ARID1B TCERG1 BRD4 MEPCE KMT2A ACIN1 | 4.59e-06 | 637 | 148 | 17 | int:SNRNP40 |
| Interaction | SOX10 interactions | 5.20e-06 | 92 | 148 | 7 | int:SOX10 | |
| Interaction | TLX1 interactions | 5.95e-06 | 175 | 148 | 9 | int:TLX1 | |
| Interaction | KLF3 interactions | 7.36e-06 | 228 | 148 | 10 | int:KLF3 | |
| Interaction | HNF1B interactions | 1.16e-05 | 190 | 148 | 9 | int:HNF1B | |
| Interaction | MYOD1 interactions | 1.37e-05 | 194 | 148 | 9 | int:MYOD1 | |
| Interaction | KPNA3 interactions | 1.53e-05 | 248 | 148 | 10 | int:KPNA3 | |
| Interaction | YAP1 interactions | TRERF1 TTF2 ATN1 ANK3 MED14 POGZ HUWE1 ARID1A PRR7 SCAF4 BPTF SETD2 ARID1B KMT2D TCERG1 TJP1 BRD4 YLPM1 SEC16A KMT2A ACIN1 GNAS | 1.65e-05 | 1095 | 148 | 22 | int:YAP1 |
| Interaction | PAX6 interactions | SOX3 BICRA POGZ ARID1A TFAP4 BPTF NCOR2 ARID1B KMT2D TLE1 TLE4 RNF111 | 1.71e-05 | 366 | 148 | 12 | int:PAX6 |
| Interaction | TBR1 interactions | 2.01e-05 | 113 | 148 | 7 | int:TBR1 | |
| Interaction | FBLN5 interactions | 2.33e-05 | 159 | 148 | 8 | int:FBLN5 | |
| Interaction | NFIC interactions | 2.56e-05 | 210 | 148 | 9 | int:NFIC | |
| Interaction | SOX7 interactions | 3.13e-05 | 82 | 148 | 6 | int:SOX7 | |
| Interaction | EYA2 interactions | 3.14e-05 | 121 | 148 | 7 | int:EYA2 | |
| Interaction | QPRT interactions | 3.60e-05 | 84 | 148 | 6 | int:QPRT | |
| Interaction | HNF4A interactions | 3.71e-05 | 275 | 148 | 10 | int:HNF4A | |
| Interaction | GATA1 interactions | 3.92e-05 | 171 | 148 | 8 | int:GATA1 | |
| Interaction | ERG interactions | 4.10e-05 | 223 | 148 | 9 | int:ERG | |
| Interaction | PAX9 interactions | 4.97e-05 | 130 | 148 | 7 | int:PAX9 | |
| Interaction | ACTL6A interactions | 5.63e-05 | 289 | 148 | 10 | int:ACTL6A | |
| Interaction | YWHAH interactions | TANC2 HIVEP2 HECTD4 HUWE1 MAP7 USP21 MAST4 FAM171A2 TCERG1 TJP1 BRD4 NECTIN2 MARK4 SEC16A MEPCE MAST1 KMT2A CSPP1 CEP170B BICC1 AGAP3 | 5.64e-05 | 1102 | 148 | 21 | int:YWHAH |
| Interaction | TERF2IP interactions | POGZ ARID1A TFAP4 BPTF NCOR2 PHC3 SETD2 SALL2 TCERG1 TJP1 BRD4 MEPCE KMT2A EPAS1 | 5.79e-05 | 552 | 148 | 14 | int:TERF2IP |
| Interaction | NUP43 interactions | USP36 ATN1 DVL1 NUP214 POGZ ARID1A BPTF NCOR2 PHC3 SETD2 ARID1B KMT2D SALL2 KMT2A ACIN1 | 5.84e-05 | 625 | 148 | 15 | int:NUP43 |
| Interaction | FOXI1 interactions | 6.01e-05 | 92 | 148 | 6 | int:FOXI1 | |
| Interaction | NUP35 interactions | ATN1 SCAF8 NUP214 ARID1A HIVEP3 NCOR2 ARID1B KMT2D TLE1 YLPM1 SEC16A BICC1 | 7.14e-05 | 424 | 148 | 12 | int:NUP35 |
| Interaction | SOX9 interactions | 8.08e-05 | 97 | 148 | 6 | int:SOX9 | |
| Interaction | CELF3 interactions | 8.13e-05 | 12 | 148 | 3 | int:CELF3 | |
| Interaction | PPIA interactions | USP36 TTF2 TCF4 ANK3 HUWE1 MBD6 ARID1A SEC31B ASAP1 SCAF4 BPTF ARID1B CHMP4A NECTIN2 SEC16A MEPCE IRF2BPL PKN3 | 9.27e-05 | 888 | 148 | 18 | int:PPIA |
| Interaction | POU5F1 interactions | TTF2 HSPG2 TCF4 ABCF1 SCAF8 HUWE1 ARID1A BPTF NCOR2 ARID1B SALL2 TCERG1 BRD4 ACIN1 | 1.05e-04 | 584 | 148 | 14 | int:POU5F1 |
| Interaction | LHX1 interactions | 1.13e-04 | 103 | 148 | 6 | int:LHX1 | |
| Interaction | GCM1 interactions | 1.43e-04 | 68 | 148 | 5 | int:GCM1 | |
| Interaction | PAX8 interactions | 1.70e-04 | 111 | 148 | 6 | int:PAX8 | |
| Interaction | FBXO22 interactions | CELF5 ABCF1 ANK3 NUP214 SCAF4 NCOR2 KRBA1 MEPCE KMT2A NID1 MICAL3 CSPP1 HYDIN | 1.80e-04 | 540 | 148 | 13 | int:FBXO22 |
| Interaction | KDM1A interactions | TRERF1 TCF4 FPGS DVL1 C8orf74 NUP214 POGZ HUWE1 NCOR2 PHC3 KMT2D SALL2 SRGAP3 TLE4 BRD4 SEC16A EPAS1 PHF21B | 1.91e-04 | 941 | 148 | 18 | int:KDM1A |
| Interaction | TNNI2 interactions | 2.08e-04 | 40 | 148 | 4 | int:TNNI2 | |
| Interaction | CTBP1 interactions | TCF4 SOBP DVL1 TFAP4 NCOR2 PHC3 BRD4 SEC16A KMT2A MAN1B1 RNF111 | 2.10e-04 | 406 | 148 | 11 | int:CTBP1 |
| Interaction | LHX4 interactions | 2.29e-04 | 166 | 148 | 7 | int:LHX4 | |
| Interaction | NANOG interactions | TRERF1 TCF4 RELB POGZ HUWE1 ARID1A USP21 BPTF NCOR2 ARID1B SALL2 SEC16A | 2.32e-04 | 481 | 148 | 12 | int:NANOG |
| Interaction | SAP30 interactions | 2.38e-04 | 167 | 148 | 7 | int:SAP30 | |
| Interaction | FOXK2 interactions | 2.63e-04 | 225 | 148 | 8 | int:FOXK2 | |
| Interaction | ETS1 interactions | 2.72e-04 | 121 | 148 | 6 | int:ETS1 | |
| Interaction | SMARCE1 interactions | 2.77e-04 | 287 | 148 | 9 | int:SMARCE1 | |
| Interaction | BRD3 interactions | ABCF1 BICRA POGZ ARID1A INO80D BPTF TCERG1 BRD4 MEPCE KMT2A ACIN1 AGAP3 | 2.95e-04 | 494 | 148 | 12 | int:BRD3 |
| Interaction | MAPRE3 interactions | 3.05e-04 | 230 | 148 | 8 | int:MAPRE3 | |
| Interaction | PAX7 interactions | 3.11e-04 | 124 | 148 | 6 | int:PAX7 | |
| Interaction | YWHAG interactions | TANC2 HIVEP2 HECTD4 HUWE1 MAP7 USP21 MAST4 FAM171A2 TCERG1 TJP1 NECTIN2 MARK4 SEC16A MEPCE KMT2A ACIN1 GNAS CSPP1 CEP170B BICC1 AGAP3 | 3.16e-04 | 1248 | 148 | 21 | int:YWHAG |
| Interaction | TEAD1 interactions | 3.27e-04 | 176 | 148 | 7 | int:TEAD1 | |
| Interaction | GIGYF1 interactions | 3.38e-04 | 177 | 148 | 7 | int:GIGYF1 | |
| Interaction | SMARCB1 interactions | FOXN1 BICRA RELB ARID1A TFAP4 ARID1B CHMP4A BRD4 KMT2A EPAS1 | 3.67e-04 | 364 | 148 | 10 | int:SMARCB1 |
| Interaction | SMC5 interactions | USP36 BICRA NUP214 POGZ ARID1A SCAF4 BPTF NCOR2 PHC3 SETD2 ARID1B TCERG1 TJP1 BRD4 YLPM1 SEC16A KMT2A ACIN1 | 3.97e-04 | 1000 | 148 | 18 | int:SMC5 |
| Interaction | IRF4 interactions | 4.08e-04 | 85 | 148 | 5 | int:IRF4 | |
| Interaction | PAX2 interactions | 4.08e-04 | 85 | 148 | 5 | int:PAX2 | |
| Interaction | SMARCD2 interactions | 4.14e-04 | 183 | 148 | 7 | int:SMARCD2 | |
| Interaction | CTNNB1 interactions | USP36 TANC2 TCF4 ANK3 DVL1 NUP214 HUWE1 USP21 KMT2D TCERG1 TJP1 TLE1 BRD4 SEC16A MAST1 KMT2A IRF2BPL EPAS1 | 4.42e-04 | 1009 | 148 | 18 | int:CTNNB1 |
| Interaction | CETN2 interactions | 4.52e-04 | 133 | 148 | 6 | int:CETN2 | |
| Interaction | GATA3 interactions | 4.71e-04 | 187 | 148 | 7 | int:GATA3 | |
| Interaction | SMAD3 interactions | ANK3 DVL1 RELB NUP214 ARID1A PRDM4 BPTF SETD2 ARID1B EPAS1 RNF111 | 4.75e-04 | 447 | 148 | 11 | int:SMAD3 |
| Interaction | NFIA interactions | 4.86e-04 | 188 | 148 | 7 | int:NFIA | |
| Interaction | DCAF4 interactions | USP36 DVL1 PATL1 NCOR2 SETD2 ARHGEF40 TJP1 FAM120C SEC16A HELZ2 | 4.92e-04 | 378 | 148 | 10 | int:DCAF4 |
| Interaction | HDAC1 interactions | TRERF1 USP36 DVL1 NUP214 ARID1A PRDM4 TFAP4 RNF157 BPTF NCOR2 KMT2D TLE1 TLE4 BRD4 KMT2A MNT EPAS1 PHF21B BAHCC1 | 4.95e-04 | 1108 | 148 | 19 | int:HDAC1 |
| Interaction | SIN3A interactions | 5.13e-04 | 380 | 148 | 10 | int:SIN3A | |
| Interaction | ASF1A interactions | 5.17e-04 | 249 | 148 | 8 | int:ASF1A | |
| Interaction | YY1 interactions | FOXN1 RELB POGZ MBD6 INO80D USP21 BPTF PHC3 BRD4 MEPCE KMT2A | 5.40e-04 | 454 | 148 | 11 | int:YY1 |
| Interaction | PRMT2 interactions | 5.59e-04 | 91 | 148 | 5 | int:PRMT2 | |
| Interaction | KLF5 interactions | 6.04e-04 | 195 | 148 | 7 | int:KLF5 | |
| Interaction | SOX15 interactions | 6.16e-04 | 141 | 148 | 6 | int:SOX15 | |
| Interaction | LHX8 interactions | 6.18e-04 | 53 | 148 | 4 | int:LHX8 | |
| Interaction | H2BC12 interactions | 6.38e-04 | 322 | 148 | 9 | int:H2BC12 | |
| Interaction | NFIB interactions | 6.39e-04 | 142 | 148 | 6 | int:NFIB | |
| Interaction | TLX2 interactions | 6.39e-04 | 142 | 148 | 6 | int:TLX2 | |
| GeneFamily | PDZ domain containing | 1.88e-04 | 152 | 99 | 6 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 6.12e-04 | 7 | 99 | 2 | 570 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.42e-04 | 34 | 99 | 3 | 487 | |
| GeneFamily | Sterile alpha motif domain containing | 1.39e-03 | 88 | 99 | 4 | 760 | |
| GeneFamily | PHD finger proteins | 1.51e-03 | 90 | 99 | 4 | 88 | |
| GeneFamily | Forkhead boxes | 1.68e-03 | 43 | 99 | 3 | 508 | |
| GeneFamily | AT-rich interaction domain containing | 2.98e-03 | 15 | 99 | 2 | 418 | |
| GeneFamily | Basic helix-loop-helix proteins | 3.13e-03 | 110 | 99 | 4 | 420 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.19e-03 | 181 | 99 | 5 | 694 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.83e-03 | 17 | 99 | 2 | 1291 | |
| GeneFamily | LIM domain containing | 4.15e-03 | 59 | 99 | 3 | 1218 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 3.39e-06 | 155 | 151 | 8 | M8944 | |
| Coexpression | PEREZ_TP53_TARGETS | FOXS1 CRYBG2 TOX ANK3 INPP5D HECTD4 ZNF385A MAP7 SCAF4 KRBA1 ARID1B ARHGEF40 ADAMTS7 MARK4 IRF2BPL CIPC MICAL3 GNAS ZNF319 CEP170B AGAP3 | 5.71e-06 | 1201 | 151 | 21 | M4391 |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP | 1.69e-05 | 193 | 151 | 8 | M6730 | |
| Coexpression | PTEN_DN.V2_DN | 1.99e-05 | 143 | 151 | 7 | M2758 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN | 2.11e-05 | 199 | 151 | 8 | M3775 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | 2.38e-05 | 147 | 151 | 7 | M2387 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | 3.78e-05 | 158 | 151 | 7 | MM934 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TRERF1 URI1 HIVEP2 TOX SCAF8 INPP5D HECTD4 IFITM1 HUWE1 ARID1A INO80D ASAP1 HIVEP3 BPTF PHC3 SETD2 KMT2D ATXN7 SRGAP3 KMT2A GNAS FYB1 | 4.66e-05 | 1492 | 151 | 22 | M40023 |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 5.34e-05 | 365 | 151 | 10 | M39018 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 6.89e-05 | 303 | 151 | 9 | M39040 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | FOXN1 CRYBG2 ANK3 TROAP LAMA2 SFI1 INO80D F12 LDB3 MAST4 SRGAP3 MICAL2 TLE4 NECTIN2 ZFHX2 PSRC1 | 7.45e-05 | 909 | 151 | 16 | M41018 |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 7.48e-05 | 176 | 151 | 7 | M8248 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 7.48e-05 | 176 | 151 | 7 | M2981 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 8.23e-05 | 40 | 151 | 4 | M5887 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | USP36 URI1 ANK3 INPP5D MED14 SFI1 SCAF4 DNAH1 PHC3 TLE4 GNAS | 9.99e-05 | 474 | 151 | 11 | M40991 |
| Coexpression | LAIHO_COLORECTAL_CANCER_SERRATED_DN | 1.34e-04 | 85 | 151 | 5 | M17423 | |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP | 1.46e-04 | 196 | 151 | 7 | M4532 | |
| Coexpression | GSE27786_BCELL_VS_NKCELL_UP | 1.66e-04 | 200 | 151 | 7 | M4805 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP | 1.66e-04 | 200 | 151 | 7 | M3589 | |
| Coexpression | GSE27786_LSK_VS_MONO_MAC_UP | 1.66e-04 | 200 | 151 | 7 | M4763 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKTCELL_DN | 1.66e-04 | 200 | 151 | 7 | M4788 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP | 1.66e-04 | 200 | 151 | 7 | M8484 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 1.66e-04 | 200 | 151 | 7 | M78 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | SHANK1 CELF5 TCF4 SGIP1 TOX HECTD4 LAMA2 SFI1 MAP7 ZFAND4 TBC1D17 HIVEP3 KIAA1549L ADAMTS7 SRGAP3 TLE4 FYB1 MNT SIX2 EPAS1 CEP170B BICC1 | 1.09e-06 | 973 | 148 | 22 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | SHANK1 TRERF1 TCF4 HIVEP2 SGIP1 ATN1 TOX TROAP INPP5D LAMA2 IFITM1 RNF157 USP21 NCOR2 PHC3 ARHGEF40 KIAA1549L ADAMTS7 TLE4 SEC16A SIX2 BICC1 | 3.33e-05 | 1208 | 148 | 22 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | TCF4 TOX FOXN4 INPP5D WASF3 LMNTD2 ZNF385A SEC31B MAP3K12 PRR7 USP21 BPTF ARID1B SALL2 FAM171A2 TCERG1 AEBP1 SRGAP3 TLE4 SIX2 PKN3 BAHCC1 | 5.23e-05 | 1245 | 148 | 22 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SHANK1 CRYBG2 TOX ANK3 SOBP MAP7 TBC1D17 HIVEP3 KIAA1549L NECTIN2 MAST1 ZFHX2 IRF2BPL SRRM3 FYB1 SIX2 EPAS1 CEP170B PLXNB1 | 5.58e-05 | 984 | 148 | 19 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 | HSPG2 ANK3 FPGS ZBTB22 DVL1 ZNF385A ZCCHC2 MBD6 TFAP4 GGT7 KIAA1549L NECTIN2 ZFHX2 IRF2BPL MICAL3 AGRN SIX2 CEP170B BICC1 PLXNB1 PKN3 BAHCC1 | 7.43e-05 | 1275 | 148 | 22 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-08 | 191 | 153 | 9 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-08 | 191 | 153 | 9 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural|World / Primary Cells by Cluster | 2.98e-08 | 198 | 153 | 9 | 9fc1035ea447a4551a66944c869c4671e17cec61 | |
| ToppCell | Non-neuronal-Postmitotic-Mural|World / Primary Cells by Cluster | 2.98e-08 | 198 | 153 | 9 | dd38840a96171f58da243daa22b013e15a81db4a | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural-18|World / Primary Cells by Cluster | 2.98e-08 | 198 | 153 | 9 | 21efb7bcd24f24d20791b34e75d6f9d46a129481 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_T_naive|Influenza_Severe / Disease, condition lineage and cell class | 3.25e-08 | 200 | 153 | 9 | 0382f8fc27d18003761725e714beb6b3f3150057 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 7.40e-08 | 157 | 153 | 8 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.14e-07 | 166 | 153 | 8 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.63e-07 | 174 | 153 | 8 | 2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.63e-07 | 174 | 153 | 8 | eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.12e-07 | 180 | 153 | 8 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|metastatic_Brain / Location, Cell class and cell subclass | 3.75e-07 | 194 | 153 | 8 | d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.75e-07 | 194 | 153 | 8 | 8a4be91414a2e69dd410aa75791f16008204c9a1 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.90e-07 | 195 | 153 | 8 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 4.05e-07 | 196 | 153 | 8 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 4.55e-07 | 199 | 153 | 8 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 4.55e-07 | 199 | 153 | 8 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 4.55e-07 | 199 | 153 | 8 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.72e-07 | 200 | 153 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.72e-07 | 200 | 153 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.72e-07 | 200 | 153 | 8 | 8b80811a0ec28d1d763c10b095d1969bccbe82d4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial-Proteoglycan-expressing_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.72e-07 | 200 | 153 | 8 | 52ec80f3922ae6ee3565d5993c2fc56bb3a3199a | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 153 | 153 | 7 | 3b1b0cc8e9dd2b1484649789330713282ee44414 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-06 | 169 | 153 | 7 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 171 | 153 | 7 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 171 | 153 | 7 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 175 | 153 | 7 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.71e-06 | 177 | 153 | 7 | 599cf7f5b774e197a1b43c98e4b9a8c1a618f38a | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 180 | 153 | 7 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 180 | 153 | 7 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 180 | 153 | 7 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-06 | 181 | 153 | 7 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-06 | 181 | 153 | 7 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.37e-06 | 183 | 153 | 7 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 3.50e-06 | 184 | 153 | 7 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-06 | 184 | 153 | 7 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.89e-06 | 187 | 153 | 7 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.03e-06 | 188 | 153 | 7 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-06 | 188 | 153 | 7 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-06 | 189 | 153 | 7 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-06 | 189 | 153 | 7 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.17e-06 | 189 | 153 | 7 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-06 | 189 | 153 | 7 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-06 | 190 | 153 | 7 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.32e-06 | 190 | 153 | 7 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 192 | 153 | 7 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-06 | 192 | 153 | 7 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 192 | 153 | 7 | 5e6f8206ee0b10cdba79a7c4a05452cb025a5512 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 192 | 153 | 7 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-06 | 192 | 153 | 7 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 192 | 153 | 7 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 192 | 153 | 7 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 192 | 153 | 7 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 192 | 153 | 7 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-06 | 192 | 153 | 7 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-06 | 192 | 153 | 7 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 192 | 153 | 7 | 136af0186c70c14c5f2b33ed7a148156de5b478c | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 4.95e-06 | 194 | 153 | 7 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.12e-06 | 195 | 153 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 195 | 153 | 7 | 223f5f07dc28fa13a09bb589884c58043c7928c7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 195 | 153 | 7 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 196 | 153 | 7 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 196 | 153 | 7 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 196 | 153 | 7 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 196 | 153 | 7 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 196 | 153 | 7 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 196 | 153 | 7 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 196 | 153 | 7 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 196 | 153 | 7 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.30e-06 | 196 | 153 | 7 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 196 | 153 | 7 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-06 | 197 | 153 | 7 | 61b1b10a017cbeb17f8529fcae66cba77ee2f115 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-06 | 197 | 153 | 7 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 197 | 153 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.48e-06 | 197 | 153 | 7 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-06 | 198 | 153 | 7 | b027a141ab531d0f5d6a26811a53427e7b0771dd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.66e-06 | 198 | 153 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-06 | 198 | 153 | 7 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-06 | 198 | 153 | 7 | 8a55589b9244283e4b0b423a4a6d6202e8e0fec9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-06 | 198 | 153 | 7 | d1f54ed3ef5e05ebda7da999e172d168dc6802cd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-06 | 198 | 153 | 7 | 953630dbe3154b1b102b87de0feca2cbf124eabe | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-06 | 198 | 153 | 7 | 8d6b0b9da7c1e64155cbcbb04ad38d129a29030c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-06 | 198 | 153 | 7 | 8e45551224fbb30c0658ad47dd98335ecf165437 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.85e-06 | 199 | 153 | 7 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 5.85e-06 | 199 | 153 | 7 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.85e-06 | 199 | 153 | 7 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-06 | 199 | 153 | 7 | 258d59cf811bf1668ffbb5f18f961021f660de62 | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.05e-06 | 200 | 153 | 7 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.05e-06 | 200 | 153 | 7 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 6.05e-06 | 200 | 153 | 7 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.05e-06 | 200 | 153 | 7 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.05e-06 | 200 | 153 | 7 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.05e-06 | 200 | 153 | 7 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 6.05e-06 | 200 | 153 | 7 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.05e-06 | 200 | 153 | 7 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.05e-06 | 200 | 153 | 7 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.12e-05 | 85 | 153 | 5 | 3f33e897eb030043905a6a1a83377cd601652958 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|World / Disease group and Cell class | 1.29e-05 | 149 | 153 | 6 | ce6552063510aa3e0b9d6e5b531eea67410e7056 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-05 | 155 | 153 | 6 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A | ATN1 ANK3 BICRA MED14 MAP3K12 HIVEP3 SALL2 FAM120C MARK4 CEP170B PLXNB1 | 8.47e-08 | 198 | 150 | 11 | 4800_DN |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A | ATN1 LAMA2 POM121L2 RELB HUWE1 INO80D AEBP1 SRGAP3 FYB1 SIX2 BAHCC1 | 9.38e-08 | 200 | 150 | 11 | 4759_UP |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | ATN1 IFITM1 ASIC3 TFAP4 HIVEP3 CSPP1 AGRN SIX2 CEP170B PLXNB1 | 6.66e-07 | 194 | 150 | 10 | 4291_DN |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; HL60; HG-U133A | 7.66e-07 | 197 | 150 | 10 | 1749_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | INO80D TFAP4 TBC1D17 MAST4 TLE1 TLE4 YLPM1 SLC24A1 SIX2 BAHCC1 | 8.40e-07 | 199 | 150 | 10 | 5601_DN |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A | 4.49e-06 | 188 | 150 | 9 | 7104_UP | |
| Drug | 5707885; Down 200; 50uM; PC3; HT_HG-U133A | 5.33e-06 | 192 | 150 | 9 | 6438_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A | 5.56e-06 | 193 | 150 | 9 | 4226_DN | |
| Drug | Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 5.80e-06 | 194 | 150 | 9 | 7410_UP | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 5.80e-06 | 194 | 150 | 9 | 3641_UP | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 6.31e-06 | 196 | 150 | 9 | 7269_UP | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 6.31e-06 | 196 | 150 | 9 | 3568_DN | |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A | 6.31e-06 | 196 | 150 | 9 | 6744_DN | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; MCF7; HT_HG-U133A | 6.84e-06 | 198 | 150 | 9 | 5672_UP | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 6.84e-06 | 198 | 150 | 9 | 6487_UP | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A | 6.84e-06 | 198 | 150 | 9 | 4838_DN | |
| Drug | Delsoline [509-18-2]; Up 200; 8.6uM; PC3; HT_HG-U133A | 6.84e-06 | 198 | 150 | 9 | 5858_UP | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 7.13e-06 | 199 | 150 | 9 | 6069_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; PC3; HT_HG-U133A | 7.13e-06 | 199 | 150 | 9 | 7318_DN | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; HL60; HT_HG-U133A | 7.42e-06 | 200 | 150 | 9 | 2558_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.99e-05 | 173 | 150 | 8 | 4665_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.16e-05 | 175 | 150 | 8 | 1058_DN | |
| Drug | hydroxysafflor yellow A | 3.25e-05 | 10 | 150 | 3 | CID006443665 | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A | 3.74e-05 | 189 | 150 | 8 | 3690_DN | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A | 4.04e-05 | 191 | 150 | 8 | 7547_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 4.04e-05 | 191 | 150 | 8 | 4454_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 4.19e-05 | 192 | 150 | 8 | 2699_DN | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A | 4.19e-05 | 192 | 150 | 8 | 3087_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 4.34e-05 | 193 | 150 | 8 | 2690_DN | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A | 4.34e-05 | 193 | 150 | 8 | 6733_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 4.51e-05 | 194 | 150 | 8 | 3539_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 4.51e-05 | 194 | 150 | 8 | 2009_DN | |
| Drug | Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A | 4.51e-05 | 194 | 150 | 8 | 5047_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | 4.51e-05 | 194 | 150 | 8 | 1264_DN | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 5265_UP | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 3525_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 3735_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; HL60; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 1836_DN | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 4991_UP | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; HL60; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 2970_UP | |
| Drug | Fillalbin [4540-25-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 4172_DN | |
| Drug | Anabasine [494-52-0]; Down 200; 24.6uM; HL60; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 2512_DN | |
| Drug | Aminocaproic acid [60-32-2]; Up 200; 30.4uM; HL60; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 3122_UP | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 2086_UP | |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; HL60; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 3132_UP | |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 5320_UP | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; HL60; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 2442_UP | |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; HL60; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 3065_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 6936_UP | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 3005_DN | |
| Drug | sulindac; Down 200; 100uM; MCF7; HG-U133A | 5.02e-05 | 197 | 150 | 8 | 168_DN | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 6055_UP | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; HL60; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 3043_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; PC3; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 4475_UP | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 1629_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 7093_UP | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 1810_DN | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 6703_UP | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 7360_UP | |
| Drug | Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; HL60; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 3110_UP | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; HL60; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 3091_DN | |
| Drug | FK-506; Down 200; 1uM; MCF7; HG-U133A | 5.21e-05 | 198 | 150 | 8 | 169_DN | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 3831_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 1522_UP | |
| Drug | Panthenol (D) [81-13-0]; Down 200; 19.4uM; PC3; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 1802_DN | |
| Drug | Scopoletin [92-61-5]; Down 200; 20.8uM; HL60; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 3131_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 5844_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 6240_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 6324_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 2725_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 2677_UP | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 4068_DN | |
| Drug | Piroxicam [36322-90-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 7445_UP | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; HL60; HT_HG-U133A | 5.59e-05 | 200 | 150 | 8 | 2988_DN | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 5.59e-05 | 200 | 150 | 8 | 3904_DN | |
| Drug | Cefotetan [69712-56-7]; Down 200; 7uM; PC3; HT_HG-U133A | 5.59e-05 | 200 | 150 | 8 | 3997_DN | |
| Drug | p-menth-1-en-3-ol | 1.29e-04 | 3 | 150 | 2 | CID000010282 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.64e-04 | 175 | 150 | 7 | 6316_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.70e-04 | 176 | 150 | 7 | 5976_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.82e-04 | 178 | 150 | 7 | 1112_DN | |
| Drug | 5109870; Down 200; 25uM; MCF7; HT_HG-U133A_EA | 1.89e-04 | 179 | 150 | 7 | 904_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.95e-04 | 180 | 150 | 7 | 5511_DN | |
| Drug | lomustine; Down 200; 100uM; PC3; HT_HG-U133A | 1.95e-04 | 180 | 150 | 7 | 7094_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.09e-04 | 182 | 150 | 7 | 1951_DN | |
| Drug | argininosuccinate | 2.19e-04 | 45 | 150 | 4 | CID000000828 | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.24e-04 | 184 | 150 | 7 | 6939_DN | |
| Drug | 2-deoxy-D-glucose; Up 200; 10000uM; MCF7; HG-U133A | 2.39e-04 | 186 | 150 | 7 | 344_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.47e-04 | 187 | 150 | 7 | 2656_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.47e-04 | 187 | 150 | 7 | 6671_DN | |
| Drug | rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 2.47e-04 | 187 | 150 | 7 | 4457_DN | |
| Drug | troglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 2.55e-04 | 188 | 150 | 7 | 4456_DN | |
| Drug | C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.63e-04 | 189 | 150 | 7 | 973_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.81e-04 | 191 | 150 | 7 | 6020_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A_EA | 2.81e-04 | 191 | 150 | 7 | 994_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A | 2.81e-04 | 191 | 150 | 7 | 3123_DN | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.81e-04 | 191 | 150 | 7 | 3861_UP | |
| Drug | Megestrol acetate [595-33-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.90e-04 | 192 | 150 | 7 | 5013_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 2.90e-04 | 192 | 150 | 7 | 1599_DN | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 2.90e-04 | 192 | 150 | 7 | 7065_DN | |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; PC3; HT_HG-U133A | 2.90e-04 | 192 | 150 | 7 | 5101_UP | |
| Disease | Neurodevelopmental Disorders | 1.06e-09 | 93 | 148 | 9 | C1535926 | |
| Disease | serum gamma-glutamyl transferase measurement | PIK3AP1 SGIP1 BICRA HECTD4 ARID1A USP21 BPTF NCOR2 SETD2 TJP1 NECTIN2 KMT2A MICAL3 PSRC1 BICC1 PKN3 BAHCC1 | 3.65e-06 | 914 | 148 | 17 | EFO_0004532 |
| Disease | Bladder Neoplasm | 7.13e-06 | 140 | 148 | 7 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 7.47e-06 | 141 | 148 | 7 | C0005684 | |
| Disease | Intellectual Disability | TANC2 HIVEP2 ATN1 POGZ BPTF SETD2 SRGAP3 BRD4 ACIN1 GNAS MAN1B1 | 1.70e-05 | 447 | 148 | 11 | C3714756 |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 2.50e-05 | 2 | 148 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | cortical thickness | CELF5 HSPG2 TCF4 LAMA2 MBD6 TFAP4 KLHL29 ZNF469 ARID1B ARHGEF40 MAST4 ADAMTS7 SRGAP3 YLPM1 KMT2A MICAL3 AGAP3 | 4.57e-05 | 1113 | 148 | 17 | EFO_0004840 |
| Disease | Teratozoospermia | 7.47e-05 | 3 | 148 | 2 | C0403824 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.06e-04 | 148 | 148 | 6 | C0279702 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.08e-04 | 49 | 148 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 1.13e-04 | 19 | 148 | 3 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | C-reactive protein measurement | TRERF1 TCF4 SGIP1 ANK3 CD248 RELB ZCCHC2 SCAF4 BPTF ZNF469 TLE4 NECTIN2 MARK4 SEC16A NID1 MICAL3 FYB1 | 1.21e-04 | 1206 | 148 | 17 | EFO_0004458 |
| Disease | Globozoospermia | 1.49e-04 | 4 | 148 | 2 | C0403825 | |
| Disease | eosinophil count | TRERF1 HIVEP2 LINC02881 FRAT1 INPP5D HECTD4 DCST2 HIVEP3 BPTF NCOR2 PHC3 SETD2 NECTIN2 MARK4 SEC16A HELZ2 ZNF319 SRRM3 BAHCC1 | 1.72e-04 | 1488 | 148 | 19 | EFO_0004842 |
| Disease | immature platelet count | 2.00e-04 | 106 | 148 | 5 | EFO_0803544 | |
| Disease | parental longevity | PIK3AP1 TOX BICRA HECTD4 ZBTB22 SFI1 MARK4 YLPM1 SRRM3 PSRC1 | 2.05e-04 | 494 | 148 | 10 | EFO_0007796 |
| Disease | Malignant Cystosarcoma Phyllodes | 2.47e-04 | 5 | 148 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 2.47e-04 | 5 | 148 | 2 | C0010701 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.47e-04 | 5 | 148 | 2 | C3281201 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2.54e-04 | 61 | 148 | 4 | C1961102 | |
| Disease | heart failure | 3.53e-04 | 185 | 148 | 6 | EFO_0003144 | |
| Disease | Nonorganic psychosis | 4.08e-04 | 69 | 148 | 4 | C0349204 | |
| Disease | family history of Alzheimer’s disease | 4.55e-04 | 71 | 148 | 4 | EFO_0009268 | |
| Disease | total blood protein measurement | 4.59e-04 | 449 | 148 | 9 | EFO_0004536 | |
| Disease | sexual dimorphism measurement | USP36 HIVEP2 CD248 POM121L2 RELB ARID1A GGT7 KLHL29 BPTF NCOR2 SSC5D ARHGEF40 NECTIN2 SEC16A SPDEF | 4.64e-04 | 1106 | 148 | 15 | EFO_0021796 |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.78e-04 | 128 | 148 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.78e-04 | 128 | 148 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.78e-04 | 128 | 148 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.78e-04 | 128 | 148 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.78e-04 | 128 | 148 | 5 | C0007134 | |
| Disease | apolipoprotein B measurement | RELB ARID1A F12 SCAF4 BPTF NECTIN2 MARK4 SRRM3 HYDIN PSRC1 PKN3 | 5.39e-04 | 663 | 148 | 11 | EFO_0004615 |
| Disease | neutrophil count | TRERF1 CELF5 HIVEP2 SGIP1 FRAT1 INPP5D HECTD4 POGZ ZCCHC2 ARID1A HIVEP3 SETD2 ATXN7 MICAL2 MARK4 HYDIN PKN3 | 5.87e-04 | 1382 | 148 | 17 | EFO_0004833 |
| Disease | thrombin measurement | 6.86e-04 | 8 | 148 | 2 | EFO_0020768 | |
| Disease | Embryonal Rhabdomyosarcoma | 6.86e-04 | 8 | 148 | 2 | C0206656 | |
| Disease | Cornelia De Lange Syndrome | 6.86e-04 | 8 | 148 | 2 | C0270972 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.91e-04 | 291 | 148 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 8.79e-04 | 9 | 148 | 2 | C0085413 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 8.79e-04 | 9 | 148 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | PR interval | 9.18e-04 | 495 | 148 | 9 | EFO_0004462 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 9.63e-04 | 224 | 148 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 9.86e-04 | 225 | 148 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | monocyte count | PIK3AP1 TTF2 TCF4 CRYBG2 LINC02881 FRAT1 INPP5D RYR1 HIVEP3 NCOR2 SETD2 MARK4 YLPM1 MAST1 SPDEF NYAP1 | 9.98e-04 | 1320 | 148 | 16 | EFO_0005091 |
| Disease | neuroblastoma (is_implicated_in) | 1.10e-03 | 10 | 148 | 2 | DOID:769 (is_implicated_in) | |
| Disease | cortical surface area measurement | TANC2 CELF5 TCF4 LINC02881 ANK3 LAMA2 MBD6 TFAP4 KLHL29 ZNF469 ARID1B MAST4 ADAMTS7 TJP1 TLE4 AGAP3 | 1.21e-03 | 1345 | 148 | 16 | EFO_0010736 |
| Disease | circadian rhythm | 1.42e-03 | 163 | 148 | 5 | EFO_0004354 | |
| Disease | platelet component distribution width | HIVEP2 WASF3 ASAP1 NCOR2 SETD2 MARK4 GNAS NYAP1 FYB1 NOS3 EPAS1 | 1.54e-03 | 755 | 148 | 11 | EFO_0007984 |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 1.58e-03 | 99 | 148 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | Congenital muscular dystrophy | 1.60e-03 | 12 | 148 | 2 | cv:C0699743 | |
| Disease | Psychotic Disorders | 1.70e-03 | 101 | 148 | 4 | C0033975 | |
| Disease | Neuroblastoma | 1.71e-03 | 47 | 148 | 3 | C0027819 | |
| Disease | body weight | HIVEP2 HECTD4 BSDC1 POM121L2 DCST2 HUWE1 PRDM4 BPTF SETD2 MAST4 SPDEF GNAS NUTM2F NOS3 EPAS1 | 1.73e-03 | 1261 | 148 | 15 | EFO_0004338 |
| Disease | hematocrit | HIVEP2 LINC02881 HECTD4 KLHL29 NCOR2 ARID1B ARHGEF40 MARK4 NYAP1 HYDIN EPAS1 BICC1 BAHCC1 | 1.79e-03 | 1011 | 148 | 13 | EFO_0004348 |
| Disease | Hypermetropia | 1.83e-03 | 103 | 148 | 4 | HP_0000540 | |
| Disease | Leukemia, Myelocytic, Acute | 1.84e-03 | 173 | 148 | 5 | C0023467 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.88e-03 | 13 | 148 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 1.88e-03 | 13 | 148 | 2 | C0265338 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 2.04e-03 | 50 | 148 | 3 | C0023453 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 2.04e-03 | 50 | 148 | 3 | EFO_0022247 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 2.10e-03 | 107 | 148 | 4 | EFO_0004614, EFO_0004615 | |
| Disease | sitting height ratio | 2.16e-03 | 51 | 148 | 3 | EFO_0007118 | |
| Disease | amyloid-beta measurement | 2.16e-03 | 355 | 148 | 7 | EFO_0005194 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.22e-03 | 264 | 148 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | corneal topography | 2.25e-03 | 109 | 148 | 4 | EFO_0004345 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 2.28e-03 | 52 | 148 | 3 | C0023452 | |
| Disease | Replication Error Phenotype | 2.51e-03 | 15 | 148 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 2.51e-03 | 15 | 148 | 2 | C0920269 | |
| Disease | Hypermetropia, Myopia | 2.70e-03 | 189 | 148 | 5 | HP_0000540, HP_0000545 | |
| Disease | lip morphology measurement | 2.70e-03 | 189 | 148 | 5 | EFO_0007845 | |
| Disease | Chromosome Aberrations | 2.86e-03 | 16 | 148 | 2 | C0008625 | |
| Disease | T-Cell Lymphoma | 2.86e-03 | 16 | 148 | 2 | C0079772 | |
| Disease | Autosome Abnormalities | 2.86e-03 | 16 | 148 | 2 | C0004403 | |
| Disease | central nervous system disease (implicated_via_orthology) | 2.86e-03 | 16 | 148 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | von Willebrand factor measurement, coronary artery disease | 3.00e-03 | 118 | 148 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | Alzheimer disease, family history of Alzheimer’s disease | 3.09e-03 | 119 | 148 | 4 | EFO_0009268, MONDO_0004975 | |
| Disease | lean body mass | 3.11e-03 | 379 | 148 | 7 | EFO_0004995 | |
| Disease | platelet crit | ARID1A KLHL29 KRBA1 ARHGEF40 THPO MAST4 TLE4 NECTIN2 MARK4 YLPM1 FYB1 PKN3 | 3.15e-03 | 952 | 148 | 12 | EFO_0007985 |
| Disease | pain | 3.16e-03 | 196 | 148 | 5 | EFO_0003843 | |
| Disease | immature granulocyte count | 3.23e-03 | 17 | 148 | 2 | EFO_0803542 | |
| Disease | loneliness measurement | 3.58e-03 | 124 | 148 | 4 | EFO_0007865 | |
| Disease | syndrome (implicated_via_orthology) | 3.63e-03 | 18 | 148 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | Alzheimer disease, amyloid-beta measurement | 3.63e-03 | 18 | 148 | 2 | EFO_0005194, MONDO_0004975 | |
| Disease | Acute Myeloid Leukemia, M1 | 3.68e-03 | 125 | 148 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 3.68e-03 | 125 | 148 | 4 | C1879321 | |
| Disease | uric acid measurement | 3.76e-03 | 610 | 148 | 9 | EFO_0004761 | |
| Disease | mean arterial pressure | 3.80e-03 | 499 | 148 | 8 | EFO_0006340 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 3.94e-03 | 63 | 148 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | Malignant Neoplasms | 4.01e-03 | 128 | 148 | 4 | C0006826 | |
| Disease | Prostatic Neoplasms | 4.01e-03 | 616 | 148 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.01e-03 | 616 | 148 | 9 | C0376358 | |
| Disease | tea consumption measurement | 4.12e-03 | 129 | 148 | 4 | EFO_0010091 | |
| Disease | cystatin C measurement | 4.28e-03 | 402 | 148 | 7 | EFO_0004617 | |
| Disease | Coronary Arteriosclerosis | 4.30e-03 | 65 | 148 | 3 | C0010054 | |
| Disease | triglycerides in small LDL measurement | 4.30e-03 | 65 | 148 | 3 | EFO_0022323 | |
| Disease | Coronary Artery Disease | 4.30e-03 | 65 | 148 | 3 | C1956346 | |
| Disease | creatinine measurement | TCF4 SCAF8 LAMA2 ARID1A F12 RYR1 GGT7 ADAMTS7 ATXN7 NECTIN2 GNAS EPAS1 | 4.47e-03 | 995 | 148 | 12 | EFO_0004518 |
| Disease | corneal hysteresis | 4.47e-03 | 20 | 148 | 2 | EFO_0010066 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.67e-03 | 215 | 148 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | Microcephaly | 4.68e-03 | 67 | 148 | 3 | C0025958 | |
| Disease | central corneal thickness | 4.79e-03 | 309 | 148 | 6 | EFO_0005213 | |
| Disease | stroke, coronary artery disease | 4.93e-03 | 21 | 148 | 2 | EFO_0000712, EFO_0001645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APAAPLLQGPPITHP | 351 | Q96PM9 | |
| PPLLTKEASSPPPHP | 416 | Q9UKV3 | |
| PILTPGHSQPIPTPG | 356 | P84996 | |
| VLSSSPKLDPPPSPH | 526 | Q96P47 | |
| PLGPPVSPPHVSTFK | 666 | Q99814 | |
| PLRHLPLPQPPSAIS | 776 | Q99814 | |
| DPPPLSPPVLGLHGV | 616 | Q8NE71 | |
| HSSSLPAPRPTGPLP | 1491 | Q9P281 | |
| LPSVPSTHLPAGPAP | 191 | Q9BY43 | |
| HQPSTLPPELPSGPP | 196 | Q8TER5 | |
| APTPIPPPITSHAGQ | 261 | Q6P047 | |
| TGPSPPIHSKPLTPA | 326 | Q9NW68 | |
| TPTTIDPIHEPPSLP | 296 | O60885 | |
| TTTLGPHTVPPTLPP | 1041 | Q8IUX7 | |
| THPTLPSAHQPPVIP | 456 | Q9HCU0 | |
| PEKGPTLAPSPHSLP | 346 | P54259 | |
| RGPTFAPLPPVAPLH | 751 | O00468 | |
| PHLPAPIPSSQLALP | 2621 | Q8IYW2 | |
| PAPPPLLLNSTDPTH | 31 | I3L1E1 | |
| PHLSSIPGGPSPSPV | 796 | Q8NFD5 | |
| LLPPPGHPSATLHPL | 4091 | Q96M86 | |
| KVPPVLPAPLTPHGT | 521 | Q9Y4F5 | |
| LPAPLTPHGTSPVGP | 526 | Q9Y4F5 | |
| PVPVPRPETTAPGAH | 531 | Q6ZUJ8 | |
| PSPPPPPAVQHTGLL | 2811 | Q12830 | |
| TAPSPPPGLTPVDVH | 541 | Q9H694 | |
| HLPPRPSSTLPPLSP | 1231 | Q9UKP4 | |
| PPVTHAPQPLLPGSV | 266 | P98160 | |
| SPAPGPGPQPHLVIT | 116 | Q01201 | |
| SPHLPGIRGPSPSPV | 686 | O14497 | |
| LTGKLEPVSPPSPPH | 141 | Q9Y618 | |
| QVPHLPVLVPPTPGT | 1736 | Q9Y618 | |
| LGHPFPPSVPPVLSP | 246 | Q86TB9 | |
| LSALAPPHGSPDPPV | 831 | Q96DN6 | |
| GHQSPLPPLVPAALP | 956 | A5PL33 | |
| VHSPSTEGPQLPPVP | 1171 | Q7RTP6 | |
| LPSKSLPHLPGTPRP | 331 | Q14244 | |
| LPHLPGTPRPTSSLP | 336 | Q14244 | |
| TTAPPVQTPLPVIPH | 91 | O75112 | |
| SPSPSVLPPSLPDLH | 421 | O60721 | |
| SHPVPPTAPLTPLLH | 281 | Q7L2J0 | |
| APVPVSQPLLTFPHP | 326 | A6NHT5 | |
| VSSEPPPLSLAGPHP | 641 | P15884 | |
| PAPSSLSTPLPEPHI | 686 | Q5VYM1 | |
| ASAAVLPPPPPHALG | 266 | Q9H1B7 | |
| HPTVPLDLPPATVPA | 811 | O43157 | |
| VLSPPPPHTGPALIS | 371 | Q9UJ14 | |
| PTPSPLGLLHPGTPD | 221 | A0A1W2PR82 | |
| PAVPTAVIPLPPGTH | 931 | P14543 | |
| PPLSAPSVPPIPSVH | 491 | Q1MSJ5 | |
| LPASHPSQPPVPSLP | 406 | O15117 | |
| HPTPLSAPPSSVPLK | 626 | P35658 | |
| LQPLPTPVLTIAPHP | 166 | Q99583 | |
| TPAFPTPTPVLTHGP | 2736 | P24043 | |
| HPSPPPPALGSLLQL | 56 | Q6ZVL6 | |
| PQHLPAIPGDPTLPS | 556 | Q8IXW0 | |
| TQVPHLSLGPRPPTP | 496 | Q9UHC3 | |
| LTLKFLHPSPPGPPT | 231 | Q6PGN9 | |
| LPIPPGLLEPHAVSS | 3096 | Q9Y4D8 | |
| PPSPGNIPTTHPLMV | 2506 | Q7Z6Z7 | |
| DPSHVSVPPPPLLLP | 656 | Q8NDX5 | |
| SPHPPLPATEPASRL | 476 | O15265 | |
| STSPTLPRPHSPLPG | 41 | Q9Y2H9 | |
| KPPLPPARTQGTPVH | 231 | Q9UKM7 | |
| VPTPPPSSHGISIGP | 1066 | O60244 | |
| APASLLPPAPEHSPP | 41 | P29474 | |
| TSALHLPSAPRPAPP | 211 | Q8TB68 | |
| PLSGPIHLSLPVPSE | 226 | A8MVW0 | |
| HLPLPPAPPTLSDLG | 61 | Q9P2D7 | |
| PQISSSPLPPGPIHR | 2176 | Q4G0P3 | |
| TPIAPASGLHSPPLL | 291 | Q8N6W0 | |
| PTHPGARLTPLVLPP | 376 | Q8N1P7 | |
| HPPPSALLPSPTFVP | 901 | Q9NX05 | |
| STGPKPLFHEVPIPP | 2146 | Q12955 | |
| PPGHKRTLSDPPSPL | 831 | Q9ULH1 | |
| EVIPGPEPSSLPIPH | 806 | Q12852 | |
| PPASPTLAHEAAPLP | 591 | Q96L34 | |
| LQRHPSSIPPPPLTA | 2126 | O15021 | |
| LLGPLSAPVHEPPSP | 236 | Q92837 | |
| PPGSLRAPLPLPTDH | 281 | O43638 | |
| HLSPLSTSLKPPAPP | 211 | Q53TQ3 | |
| QPPSPPKGLLTHPVA | 536 | Q05932 | |
| DSPTPLHPPTPPILS | 1836 | Q03164 | |
| ATAPGLPPPHPTTKA | 636 | O14640 | |
| PVSILTSPEPHRPPE | 726 | Q5T1A1 | |
| PGHPTPPATLPSEPV | 306 | Q8N9H9 | |
| SPPLPLPGTVPDPHT | 1806 | Q9BYK8 | |
| TPPPTLHLVPEPAAP | 921 | Q9NZM4 | |
| VSIPPPHTPPISIPN | 751 | O95104 | |
| GIPPPSVLDSALHPP | 951 | Q9UPN6 | |
| HKPTPAPSPALPGST | 296 | Q9Y467 | |
| PPATPTLPRLPHDVV | 1401 | P21817 | |
| PLSQVSRGHPSPPTP | 1311 | O94851 | |
| THSAIPAPGLPVAIP | 41 | Q9UKN5 | |
| PLSTAHPLTPPSLPP | 1136 | A6NGG8 | |
| PPALTPPAPHSLLTA | 856 | Q6P5Z2 | |
| HEVAVLGPPPSTILP | 6 | P13164 | |
| LASPHSLPDPTVGPL | 531 | Q6ZVC0 | |
| ATPAPGPAHRPPLVT | 31 | A1L443 | |
| GPAHRPPLVTAVVPP | 36 | A1L443 | |
| ATPSPGPTHRPPLVT | 31 | Q5VZR2 | |
| GPTHRPPLVTAVVPP | 36 | Q5VZR2 | |
| AAPPTPVSPRLHVPL | 301 | P00748 | |
| TPPLHALPDLSPSPL | 381 | Q96NZ1 | |
| PTALVPHSPLPGALS | 1051 | A8K8P3 | |
| PSPPATLAHLLPAPA | 61 | P41225 | |
| SVLFHTTGPAPLPPP | 581 | A6NNA2 | |
| LTPPPAIAHPALPTI | 491 | O94763 | |
| PLTPSPAVPPLHVLG | 376 | Q96PX1 | |
| SPGALPPPHPSLGLT | 81 | Q6BEB4 | |
| PPPHPSLGLTPQKTH | 86 | Q6BEB4 | |
| VCPPVPRPSLPGTHA | 296 | Q7Z3H4 | |
| RPLAPPAGLSPPLHS | 411 | O15353 | |
| TPPPTPTHPQALALP | 916 | Q7Z3K3 | |
| GPESPHRPSLIPPVT | 286 | Q92835 | |
| GLPVIQSPPSSPPHR | 1436 | Q9HCD6 | |
| SVLPTTGILTPHPGP | 976 | Q9NQW1 | |
| HPPLDPLTLGPTPGQ | 1451 | A1L4H1 | |
| AHSPLKTPSLPTPPG | 431 | Q96KW2 | |
| SPPPPPALLHCLSTG | 311 | Q7RTU9 | |
| ESPLTPGPPHPLPDT | 1581 | Q9Y566 | |
| QLLFLHPPVPSPVSP | 126 | Q9C0C6 | |
| SLGTTPPHPLPPTGS | 16 | B7Z368 | |
| TVPPAVPTHTPGPAP | 956 | Q9C0B9 | |
| ILGLAPPAEPHSPSP | 591 | Q9HA65 | |
| VPLTPHPSGLQPPGI | 141 | Q04724 | |
| HGVPLPGSPPPTVAL | 86 | Q9UK80 | |
| LDSPVPHLGPPFLVP | 1541 | Q9C0A1 | |
| TASSPPHLPSKRLPP | 286 | Q4G0A6 | |
| LHPSSLPLTPPSPSL | 206 | Q96EK2 | |
| APPPPTHLASTAAPI | 706 | Q6ZNA4 | |
| PLLAVPAPSPEHSSP | 1931 | O15027 | |
| PPGPVSSEPASPLHT | 1001 | O43295 | |
| PPAVPHSVPQPTTAI | 341 | O14776 | |
| VPLTPHPSGLQPPAI | 146 | Q04727 | |
| HPSGLQPPAIPPIGS | 151 | Q04727 | |
| SPPIHSSSPPPIAPL | 486 | Q9BQI5 | |
| HGSVPIIVPLIPPPF | 121 | A7XYQ1 | |
| PGLSSVSPSHLLLPP | 6 | O95238 | |
| SHESPVLPPPQPLSL | 541 | Q6ZQQ2 | |
| APPHPPSTGLLVTAP | 381 | Q9UPY6 | |
| QHPPSTAPPVPLLRS | 526 | Q5T1R4 | |
| PSPAPVAQPLPGHVV | 306 | Q12815 | |
| LLLSPPPPGLPSLHS | 231 | Q9NPC8 | |
| GHSTEPLSAPPPVPV | 2211 | Q9BYW2 | |
| AIPSAPVLPPPPVHS | 1601 | P49750 | |
| SPHGTPSLPPPRVVG | 571 | Q96JG9 | |
| SPGLLIPEQPPPSRH | 1231 | Q96JG9 | |
| PLHGAAAVPPLIPSS | 1216 | Q07157 | |
| EPPPALAEHTLPPGT | 26 | Q9P2F9 | |
| SPPPPPALLHCLSTG | 311 | A6NGW2 | |
| IKPHPPVAPRPSSGS | 246 | Q86XD8 | |
| PPALSSLHPSPTLPL | 2241 | P31629 | |
| TQLLPPPAPTHHPTV | 221 | Q01664 | |
| PPITPPSLPDHSLVH | 71 | O94900 | |
| PPPLPLPAAAVVHVS | 21 | O15209 | |
| SPHPTLLSSTPKPPG | 756 | Q9P275 | |
| KTTTGPPHLVPPQPL | 481 | Q9UNY4 | |
| AHPQLPLTPLTPTPR | 736 | Q96PN7 | |
| HPLLPDPSAPTPTPT | 321 | P40225 | |
| PVIGVTPSLPPHVGP | 181 | Q96CT2 | |
| PPAHLLTPSPLSGPG | 3191 | O14686 | |
| LSTGPVLGPVHPTPP | 4296 | O14686 | |
| VLGPVHPTPPPSSPQ | 4301 | O14686 | |
| PPAHVPPTLLTLQEP | 176 | Q8NBZ9 | |
| PLHPGATSLGSPIPV | 466 | Q92692 |